Kilitch Drugs (India) Limited (NSE:KILITCH)
India · Delayed Price · Currency is INR 215.75
-5.87 (-2.65%)
Sep 24, 2026, 3:29 PM IST
Kilitch Drugs (India) Market Cap
Kilitch Drugs (India) has a market cap or net worth of 7.83 billion as of September 23, 2026. Its market cap has increased by 38.07% in one year.
Market Cap
7.83B
Enterprise Value
8.00B
Revenue
2.37B
Ranking
n/a
PE Ratio
26.04
Stock Price
215.75
ChartMarket Cap Chart
Since March 5, 2002, Kilitch Drugs (India)'s market cap has increased from 14.33M to 7.83B, an increase of 54,504.46%. That is a compound annual growth rate of 29.24%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 23, 2026 | 7.83B | 38.70% |
| Dec 31, 2025 | 5.64B | 7.84% |
| Dec 31, 2024 | 5.23B | -12.48% |
| Dec 29, 2023 | 5.98B | 145.95% |
| Dec 30, 2022 | 2.43B | -37.79% |
| Dec 31, 2021 | 3.91B | 162.68% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sakar Healthcare | 26.25B |
| Indoco Remedies | 22.98B |
| Windlas Biotech | 22.89B |
| Beta Drugs | 20.83B |
| Jagsonpal Pharmaceuticals | 15.06B |
| Anlon Healthcare | 12.17B |
| Sigachi Industries | 11.31B |
| Bafna Pharmaceuticals | 7.65B |